Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.7.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at Jun. 30, 2015 $ 9,053,807 $ 24,341 $ 38,138,754 $ (29,109,288)
Balance (in shares) at Jun. 30, 2015   24,338,219    
Stock-based compensation 3,761,837 $ 0 3,761,837 0
Fair value of warrants issued 5,523,706 0 5,523,706 0
Dividends on Series A Preferred Stock (5,974,385) 0 (5,974,385) 0
Conversion of Series A Preferred Stock into common stock 5,307,909 $ 5,897 5,302,012 0
Conversion of Series A Preferred Stock into common stock (in shares)   5,897,677    
Exchange on Series A Preferred Stock 2,929,084 $ 0 2,929,084 0
Issuance of common stock 3,106,437 $ 4,876 3,101,561 0
Issuance of common stock (in shares)   4,875,020    
Net loss (14,935,542) $ 0 0 (14,935,542)
Balance at Jun. 30, 2016 8,772,853 $ 35,114 52,782,569 (44,044,830)
Balance (in shares) at Jun. 30, 2016   35,110,916    
Stock-based compensation 3,537,963 $ 0 3,537,963 0
Fair value of warrants issued 5,145,032 0 5,145,032 0
Deemed dividend on warrant modification (3,366,070) 0 (3,366,070) 0
Issuance of common stock 8,399,343 $ 10,282 8,389,061 0
Issuance of common stock (in shares)   10,283,184    
Conversion of note payable into common stock 59,517 $ 58 59,459 0
Conversion of note payable into common stock (in shares)   58,350    
Net loss (14,088,396) $ 0 0 (14,088,396)
Balance at Mar. 31, 2017 $ 8,460,242 $ 45,454 $ 66,548,014 $ (58,133,226)
Balance (in shares) at Mar. 31, 2017   45,452,450